Literature DB >> 623979

Atopy and immunoglobulin E concentrations in Hodgkin's disease and other lymphomas.

P L Amlot, L A Green.   

Abstract

Serum immunoglobulin E (IgE) concentrations are increased in Hodgkin's disease (HD) but not in other types of lymphoma. The prevalence of atopic disease is similar to normal in both groups. Patients with high IgE concentrations and HD were separated into atopic and non-atopic groups, which were found to differ clinically. Atopic patients had a significantly lower incidence of night sweats, fever, and weight loss, and treatment had no significant lasting effect on their IgE concentrations. In the non-atopic group there was a striking correlation between high IgE concentrations and a histological appearance of nodular sclerosis, particularly in the presence of night sweats, fever, and weight loss. Successful treatment in the non-atopic group led to a noticeable fall in IgE concentrations, in most cases to normal, though on relapse of the disease they rose again.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 623979      PMCID: PMC1602883          DOI: 10.1136/bmj.1.6109.327

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  12 in total

1.  Hodgkin's disease and allergy.

Authors:  M DWORIN; H D DIAMOND; L F CRAVER
Journal:  Cancer       Date:  1955 Jan-Feb       Impact factor: 6.860

2.  A detailed investigation of circulating IgE levels in a normal population.

Authors:  L Nye; T G Merrett; J Landon; R J White
Journal:  Clin Allergy       Date:  1975-03

3.  Potentiation of rat reaginic (IgE) antibody by helminth infection. Simultaneous potentiation of separate reagins.

Authors:  E E Jarrett; D C Stewart
Journal:  Immunology       Date:  1972-11       Impact factor: 7.397

4.  Effect of lymphocytosis-promoting factor of Bordetella pertussis on the immune response. I. Suppression of cellular hypersensitivity reactions.

Authors:  T Ochiai; K Okumura; T Tada; S Iwasa
Journal:  Int Arch Allergy Appl Immunol       Date:  1972

5.  Raised levels of a new immunoglobulin class (IgND) in asthma.

Authors:  S G Johansson
Journal:  Lancet       Date:  1967-11-04       Impact factor: 79.321

6.  Report of the Committee on Hodgkin's Disease Staging Classification.

Authors:  P P Carbone; H S Kaplan; K Musshoff; D W Smithers; M Tubiana
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

7.  Combination chemotherapy in the treatment of advanced Hodgkin's disease.

Authors:  V T Devita; A A Serpick; P P Carbone
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

Review 8.  Regulation of reaginic antibody formation in animals.

Authors:  T Tada
Journal:  Prog Allergy       Date:  1975

9.  IgE levels in sera of cancer patients.

Authors:  W D Winters; D C Heiner
Journal:  J Allergy Clin Immunol       Date:  1976-02       Impact factor: 10.793

10.  A critical search for evidence of changes in levels of circulating IgE in patients with cancer.

Authors:  P McLaughlan; D R Stanworth
Journal:  Lancet       Date:  1975-01-11       Impact factor: 79.321

View more
  7 in total

1.  A protective role for early oral exposures in the etiology of young adult Hodgkin lymphoma.

Authors:  Wendy Cozen; Ann S Hamilton; Peng Zhao; Muhammad T Salam; Dennis M Deapen; Bharat N Nathwani; Lawrence M Weiss; Thomas M Mack
Journal:  Blood       Date:  2009-09-08       Impact factor: 22.113

2.  IgE, T cells and transfer factor in mycosis fungoides.

Authors:  H Zachariae; E Grunnet; J Ellegaard; K Thestrup-Pedersen
Journal:  Br Med J       Date:  1978-04-01

3.  Elevated Serum Levels of sCD30 and IL6 and Detectable IL10 Precede Classical Hodgkin Lymphoma Diagnosis.

Authors:  Lynn I Levin; Elizabeth C Breen; Brenda M Birmann; Julie L Batista; Larry I Magpantay; Yuanzhang Li; Richard F Ambinder; Nancy E Mueller; Otoniel Martínez-Maza
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-03-24       Impact factor: 4.254

4.  Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.

Authors:  S Romagnani; G F Del Prete; E Maggi; G Bellesi; G Biti; P L Rossi Ferrini; M Ricci
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

5.  Trial of a centralized IgE allergy service to general practitioners in a rural area.

Authors:  J H Parker; R M Moore; R S Wilson
Journal:  J R Coll Gen Pract       Date:  1981-04

6.  Clinical, molecular, and environmental risk factors for hodgkin lymphoma.

Authors:  Alison Maggioncalda; Neha Malik; Pareen Shenoy; Melody Smith; Rajni Sinha; Christopher R Flowers
Journal:  Adv Hematol       Date:  2010-11-29

7.  Atopy--a favourable prognostic factor for survival in Hodgkin's disease.

Authors:  P L Amlot; J Slaney; R Brown
Journal:  Br J Cancer       Date:  1983-08       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.